We are live on ! Find out more
STIM icon

Neuronetics

99 hedge funds and large institutions have $57.8M invested in Neuronetics in 2025 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

513% more call options, than puts

Call options by funds: $4.34M | Put options by funds: $708K

82% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 11

81% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 21

10% more funds holding

Funds holding: 9099 (+9)

4.55% more ownership

Funds ownership: 27.49%32.04% (+4.6%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less capital invested

Capital invested by funds: $63.1M → $57.8M (-$5.31M)

Holders
99
Holders Change
+9
Holders Change %
+10%
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
20
Increased
38
Reduced
21
Closed
11
Calls
$4.34M
Puts
$708K
Net Calls
+$3.63M
Net Calls Change
+$3.7M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
26
Centiva Capital
New York
$320K +$218K +61,501 +110%
Bank of America
27
Bank of America
North Carolina
$313K +$111K +31,353 +38%
Charles Schwab
28
Charles Schwab
California
$290K
Two Sigma Advisers
29
Two Sigma Advisers
New York
$284K -$189K -53,200 -34%
Group One Trading
30
Group One Trading
Illinois
$262K +$291K +81,860 +586%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$222K +$4.67K +1,315 +2%
GI
32
GAMCO Investors
Connecticut
$216K +$7.11K +2,000 +3%
ECM
33
ExodusPoint Capital Management
New York
$198K +$257K +72,384 New
BCM
34
Bridgeway Capital Management
Texas
$192K
Squarepoint
35
Squarepoint
New York
$171K +$37K +10,423 +20%
MG
36
Marex Group
$164K +$214K +60,200 New
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$152K +$11.1K +3,119 +6%
Barclays
38
Barclays
United Kingdom
$141K -$41.6K -11,715 -18%
CCA
39
Cruiser Capital Advisors
Connecticut
$137K
N
40
Nuveen
North Carolina
$128K
Fidelity Investments
41
Fidelity Investments
Massachusetts
$128K +$1.18K +331 +0.7%
AC
42
AXQ Capital
New Jersey
$124K +$161K +45,284 New
Deutsche Bank
43
Deutsche Bank
Germany
$120K +$152K +42,901 +4,521%
BCM
44
Bluefin Capital Management
New York
$117K +$152K +42,705 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$110K +$142K +39,935 +20,068%
GF
46
Gabelli Funds
New York
$104K
T. Rowe Price Associates
47
T. Rowe Price Associates
Maryland
$101K
LPL Financial
48
LPL Financial
California
$95.8K +$125K +35,100 New
Invesco
49
Invesco
Georgia
$89.4K +$14.7K +4,134 +14%
National Bank of Canada
50
National Bank of Canada
Quebec, Canada
$87K +$24.4K +6,880 +28%

STIM Hedge Fund Activity: Q3 2025 in Review

99 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q3 2025, worth a combined $57.8M — down 8.4% from $63.1M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new STIM positions and 11 closed out — a net gain of 9 holders — while 38 added to existing stakes and 21 trimmed.

The largest buyer was UBS Group, adding an estimated $6.56M. The largest seller was Manatuck Hill Partners, exiting entirely with an estimated $3.21M sold.

  • 99 institutional investors held Neuronetics (STIM) as of Q3 2025, up from 90 in Q2 2025.
  • Funds reported $57.8M of Neuronetics stock for Q3 2025, down 8.4% quarter-over-quarter.
  • 20 funds opened new Neuronetics positions in Q3 2025 and 11 closed out, a net change of +9 holders.
  • The largest Neuronetics buyer in Q3 2025 was UBS Group, an estimated $6.56M added.
  • The largest Neuronetics seller in Q3 2025 was Manatuck Hill Partners, an estimated $3.21M sold.

Based on aggregated 13F filings for Q3 2025.